Literature DB >> 22081344

Antibody validation by Western blotting.

Michele Signore1, K Alex Reeder.   

Abstract

Validation of antibodies is an integral part of translational research, particularly for biomarker discovery. Validation is essential to show the specificity of the reagent (antibody) and to confirm the identity of the protein biomarker, prior to implementing the biomarker in clinical studies.Antibody validation is the procedure in which a single antibody is thoroughly assayed for sensitivity and specificity. Although a plethora of commercial antibodies exist, antibody specificity must be thoroughly demonstrated using a complex biological sample, rather than a recombinant protein, prior to use in clinical translational research. In the simplest iteration, antibody specificity is determined by the presence of a single band in a complex biological sample, at the expected molecular weight, on a western blot.Numerous western blotting procedures are available, spanning the spectrum of single blots to multiplex blots, with images and quantitation generated by manual or automated systems. The basic principles of western blotting are (a) separation of protein mixtures by gel electrophoresis, (b) transfer of the proteins to a blot, (c) probing the blot for a protein or proteins of interest, and (d) subsequent detection of the protein by chemiluminescent, fluorescent, or colorimetric methods. This chapter focuses on the chemiluminescent detection of proteins using a manual western blotting system and a vacuum-enhanced detection system (SNAP i.d.™, Millipore).

Mesh:

Substances:

Year:  2012        PMID: 22081344     DOI: 10.1007/978-1-60327-216-2_10

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  17 in total

1.  A pilot study exploring the molecular architecture of the tumor microenvironment in human prostate cancer using laser capture microdissection and reverse phase protein microarray.

Authors:  Elisa Pin; Steven Stratton; Claudio Belluco; Lance Liotta; Ray Nagle; K Alex Hodge; Jianghong Deng; Ting Dong; Elisa Baldelli; Emanuel Petricoin; Mariaelena Pierobon
Journal:  Mol Oncol       Date:  2016-10-14       Impact factor: 6.603

2.  Enrichment of PI3K-AKT-mTOR Pathway Activation in Hepatic Metastases from Breast Cancer.

Authors:  Mariaelena Pierobon; Corinne Ramos; Shukmei Wong; K Alex Hodge; Jessica Aldrich; Sara Byron; Stephen P Anthony; Nicholas J Robert; Donald W Northfelt; Mohammad Jahanzeb; Linda Vocila; Julia Wulfkuhle; Guido Gambara; Rosa I Gallagher; Bryant Dunetz; Nicholas Hoke; Ting Dong; David W Craig; Massimo Cristofanilli; Brian Leyland-Jones; Lance A Liotta; Joyce A O'Shaughnessy; John D Carpten; Emanuel F Petricoin
Journal:  Clin Cancer Res       Date:  2017-04-26       Impact factor: 12.531

3.  Identification of a Cyclospora cayetanensis Oocyst Antigens and Their Validity in the Detection of Immunogenic Patterns of Cyclosporiasis Patients.

Authors:  Eman M Hussein; Eman K El-Gayar; Ola A Ismail; Amira B Mokhtar; Maha M Al-Abbassy
Journal:  Acta Parasitol       Date:  2020-10-10       Impact factor: 1.440

4.  Functional and biological heterogeneity of KRASQ61 mutations.

Authors:  Minh V Huynh; G Aaron Hobbs; Antje Schaefer; Mariaelena Pierobon; Leiah M Carey; J Nathaniel Diehl; Jonathan M DeLiberty; Ryan D Thurman; Adelaide R Cooke; Craig M Goodwin; Joshua H Cook; Lin Lin; Andrew M Waters; Naim U Rashid; Emanuel F Petricoin; Sharon L Campbell; Kevin M Haigis; Diane M Simeone; Costas A Lyssiotis; Adrienne D Cox; Channing J Der
Journal:  Sci Signal       Date:  2022-08-09       Impact factor: 9.517

5.  Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer.

Authors:  Kirsten L Bryant; Clint A Stalnecker; Daniel Zeitouni; Jennifer E Klomp; Sen Peng; Andrey P Tikunov; Venugopal Gunda; Mariaelena Pierobon; Andrew M Waters; Samuel D George; Garima Tomar; Björn Papke; G Aaron Hobbs; Liang Yan; Tikvah K Hayes; J Nathaniel Diehl; Gennifer D Goode; Nina V Chaika; Yingxue Wang; Guo-Fang Zhang; Agnieszka K Witkiewicz; Erik S Knudsen; Emanuel F Petricoin; Pankaj K Singh; Jeffrey M Macdonald; Nhan L Tran; Costas A Lyssiotis; Haoqiang Ying; Alec C Kimmelman; Adrienne D Cox; Channing J Der
Journal:  Nat Med       Date:  2019-03-04       Impact factor: 53.440

6.  Atypical KRASG12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer.

Authors:  G Aaron Hobbs; Nicole M Baker; Anne M Miermont; Ryan D Thurman; Mariaelena Pierobon; Timothy H Tran; Andrew O Anderson; Andrew M Waters; J Nathaniel Diehl; Bjoern Papke; Richard G Hodge; Jennifer E Klomp; Craig M Goodwin; Jonathan M DeLiberty; Junning Wang; Raymond W S Ng; Prson Gautam; Kirsten L Bryant; Dominic Esposito; Sharon L Campbell; Emanuel F Petricoin; Dhirendra K Simanshu; Andrew J Aguirre; Brian M Wolpin; Krister Wennerberg; Udo Rudloff; Adrienne D Cox; Channing J Der
Journal:  Cancer Discov       Date:  2019-10-24       Impact factor: 38.272

7.  Functional signaling pathway analysis of lung adenocarcinomas identifies novel therapeutic targets for KRAS mutant tumors.

Authors:  Elisa Baldelli; Guido Bellezza; Eric B Haura; Lucio Crinó; W Douglas Cress; Jianghong Deng; Vienna Ludovini; Angelo Sidoni; Matthew B Schabath; Francesco Puma; Jacopo Vannucci; Annamaria Siggillino; Lance A Liotta; Emanuel F Petricoin; Mariaelena Pierobon
Journal:  Oncotarget       Date:  2015-10-20

8.  Features of MRI stromal enhancement with neoadjuvant chemotherapy: a subgroup analysis of the ACRIN 6657/I-SPY TRIAL.

Authors:  Adam Olshen; Denise Wolf; Ella F Jones; David Newitt; Laura J van ‘t Veer; Christina Yau; Laura Esserman; Julia D Wulfkuhle; Rosa I Gallagher; Lisa Singer; Emanuel F Petricoin; Nola Hylton; Catherine C Park
Journal:  J Med Imaging (Bellingham)       Date:  2017-12-23

9.  Kinase-driven metabolic signalling as a predictor of response to carboplatin-paclitaxel adjuvant treatment in advanced ovarian cancers.

Authors:  Maria Isabella Sereni; Elisa Baldelli; Guido Gambara; Antonella Ravaggi; K Alex Hodge; David S Alberts; Jose M Guillen-Rodriguez; Ting Dong; Maurizio Memo; Franco Odicino; Roberto Angioli; Lance A Liotta; Sergio L Pecorelli; Emanuel F Petricoin; Mariaelena Pierobon
Journal:  Br J Cancer       Date:  2017-06-29       Impact factor: 7.640

10.  Extensive three-dimensional intratumor proteomic heterogeneity revealed by multiregion sampling in high-grade serous ovarian tumor specimens.

Authors:  Allison L Hunt; Nicholas W Bateman; Waleed Barakat; Sasha Makohon-Moore; Brian L Hood; Kelly A Conrads; Ming Zhou; Valerie Calvert; Mariaelena Pierobon; Jeremy Loffredo; Tracy J Litzi; Julie Oliver; Dave Mitchell; Glenn Gist; Christine Rojas; Brian Blanton; Emma L Robinson; Kunle Odunsi; Anil K Sood; Yovanni Casablanca; Kathleen M Darcy; Craig D Shriver; Emanuel F Petricoin; Uma N M Rao; G Larry Maxwell; Thomas P Conrads
Journal:  iScience       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.